During the years the National Congress on Diseases of the respiratory system has been a significant development, have contributed significantly to the development of respiratory medicine and promoting continuing education of physicians. Specialists of various levels of knowledge - from the heads of departments and agencies, academicians and professors, managers of pharmaceutical companies and pharmaceutical institutions, medical practitioners, to young scientists, students of higher medical and pharmaceutical educational institutions - will be able to find answers to their questions.

The uniqueness of the upcoming Congress - an attempt to look at the man with the pathology of respiratory organs in a complex with all its attendant diseases. At the upcoming forum scheduled multidisciplinary approach to address the latest advances in respiratory medicine and pharmacology, innovative methods of diagnosis and treatment of common and rare diseases rights issues to minimize the risks of drug therapy. Will be given due attention to issues of diagnosis and therapy of acute infectious diseases, including HIV, influenza, TB. The Congress will be able to see the latest achievements in thoracic surgery, lung transplantation, international recommendations for the management of patients with bronchial asthma, COPD, sarcoidosis and other diseases of the respiratory system. The high scientific and educational level of the Forum will ensured by the participation of leading specialists from different fields of medicine, domestic and foreign scientists.

A feature of National Congress on Diseases of the respiratory system is the using of new information technologies in the practice of teaching physicians: a teleconference with key national leaders that will provide an opportunity to expand the audience of students from many regions of Russia. With the scientific program of the Congress is closely related exhibition of modern medicine, new information technologies, medical products, and specialized publications. The exhibition gives to many thousands audience of Congress a real opportunity to get acquainted with the latest developments of domestic and foreign pharmaceutical companies.